Lure of profits laid groundwork for some Covid-19 treatments, though may not determine who finds a cure. Not long ago, drug companies had a bull’s-eye on their ticker symbols. Sky-high prices for lifesaving drugs and the opioid crisis had made them the country’s least-liked industry. Democratic presidential candidates were one-upping each